info@pericardcheck.de

+49 (0) 415 2889 246

Facebook Instagram Linkedin Youtube X-twitter

About Us

PeriCard Check GmbH > About Us

About Us

ABOUT PeriCard Check GmbH

PeriCard Check GmbH is a German-based medical device company focused on cardiovascular point-of-care diagnostics. We develop and distribute point-of-care diagnostic solutions — with ASTRID®, our proprietary rapid test platform, at the core of our portfolio.

HOURS & PRICING

We look forward to seeing you!

LEARN MORE

Committed to Ethical Preclinical Testing Methods

We are committed to ethical preclinical testing methods that prioritize scientific integrity, animal welfare, and responsible innovation. Our work is governed by a Quality Management System certified to ISO 13485 – Medical devices, ensuring rigorous oversight and full compliance with applicable European Union and German regulations, including AMG and MPDG. This framework reflects our dedication to developing medical devices that are safe, traceable, and held to the highest regulatory standards.

Driving the Future of
Cardiovascular Care

Our Mission

We aim to empower healthcare providers and patients to access rapid, accurate, and affordable clinical diagnostics that adhere to the highest quality standards. Through continuous innovation and improvement, we strive to advance healthcare and enhance patient outcomes.

Our Vision

To be recognized globally as a leader in using biomarkers for delivering high–quality testing, setting the standards for scientific excellence, and innovative solutions for the detection and monitoring of a wide range of cardiovascular
diseases.

Our EXPERT TEAM

Immunoassay Technology
94%

PeriCard Check GmbH is a diagnostics company specializing in cardiac biomarker development. Rooted in biochemistry and immunoassay science, our team translates complex laboratory research into practical, point-of-care diagnostic tools.

Point-of-Care Diagnostics
88%

Our team develops point-of-care testing solutions designed for speed, accuracy, and ease of use in clinical settings. ASTRID®, our flagship rapid test, is developed in accordance with IVDR requirements.

Cardiovascular Research
84%

We are driven by the science of cardiovascular disease, researching and validating biomarkers that provide clinically meaningful insights into cardiac health. Our goal is to support a shift from reactive treatment toward earlier, more precise cardiovascular assessment.

How it works

The Science Behind ASTRID: Why This Biomarker Matters

For decades, clinicians have faced a diagnostic gap — patients presenting with serious cardiac impairment that conventional markers fail to detect. ASTRID® addresses this by:

Measuring Functional Resilience

Capturing the heart's physiological response to stress, rather than relying solely on markers of cell damage or necrosis.

Early Detection

Identifying cardiac stress long before structural injury occurs, which is key to detecting the risk of sudden cardiac death (SCD).

Predictive Care

Supporting a shift from reactive treatment to predictive cardiovascular medicine, by providing insight into the biological trajectory of the heart.

Focusing Your Mind, with The
Best Expert.

Read More

Target Audience &
Impact

  • Emergency Departments: Enabling rapid triage and treatment decisions to reduce dependency on delayed imaging.
  • Sports Medicine: Offering the first objective method to detect functional cardiac instability in athletes before sudden cardiac events.
  • Preventive Cardiology: Annual screening for adults to detect sub-clinical shifts in heart health.